Novartis India Limited - pharma in Bandra, Maharashtra, India. FY 2026 financials and compliance.
CIN L24200MH1947PLC006104 Incorporated 13 December 1947 ROC Mumbai HQ Bandra, Maharashtra, India
Active Listed - NSE: NOVARTIND · BSE: 500672 Public Limited Company pharma
Data last updated
Revenue · FY 2025
₹398.23 Cr
▲ 0.88% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹32 Cr
Registered with MCA
Paid-up capital
₹12.35 Cr
Issued & subscribed
Open charges
None
Satisfied ₹257.48 Cr
Company age
79 yrs
Est. 1947
Employees · EPFO
59
Latest available

About Novartis India Limited

Data last updated: 14 July 2026

Novartis India Limited is a public limited company based in Bandra, Maharashtra, India, a subsidiary of Novartis Ag. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 13 December 1947, the company has been in operation for over 79 years.

Registered with ROC Mumbai under CIN L24200MH1947PLC006104. Listed on BSE: 500672 and NSE: NOVARTIND.

Capital: an authorised share capital of ₹32 Cr and a paid-up capital of ₹12.35 Cr. Formerly known as Ciba (India) Private Limited and Ciba (India) Limited. It is led by directors including Sanker Parameswaran and Shilpa Shashank Joshi.

Last AGM: 31 July 2025. Financial statements filed for year ended 31 March 2025. Office: Inspire Bkc 7Th Floor Bandra Kurla Complex, Bandra East, Maharashtra, India – 400051.

As per the financials filed for FY 2025, the company reported a revenue of ₹398.23 Cr, a growth of 0% compared to the previous year.

The company has a workforce of approximately 59 employees as per the latest available data. It operates as a subsidiary of Novartis Ag.

As per MCA filings, the company has satisfied charges of ₹257.48 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website novartis.in.

Company Details of Novartis India Limited
CIN L24200MH1947PLC006104
Registration Number 006104
Incorporation Date 13 December 1947
ROC Mumbai
Listing Status Listed (BSE: 500672, NSE: NOVARTIND)
Company Status Active
Date of Last AGM 31 July 2025
Date of Balance Sheet 31 March 2025
Parent Company Novartis Ag
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
  • Registered Address
    Inspire Bkc 7Th Floor Bandra Kurla Complex, Bandra East, Maharashtra, India – 400051
  • Industry
    Pharma, Drug Formulation & Development
Company report
Novartis India Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Novartis India Limited report

Financials, compliance, directors, charges, ownership and filings for Novartis India Limited in one report.

10-year financials Directors & ownership Charges & compliance

Name History of Novartis India Limited

Novartis India Limited has undergone 2 name changes throughout its history. The company was previously known as Ciba (India) Private Limited, and Ciba (India) Limited. The current legal name is Novartis India Limited, reflecting the company's evolution and rebranding over time.

Company Name Status
Novartis India Limited Current
Ciba (India) Private Limited Previous
Ciba (India) Limited Previous

Business Activity of Novartis India Limited

Novartis India Limited is engaged in the principal business activity of trade, with detailed activities including wholesale trading.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
G Trade G1 Wholesale Trading Locked
Premium access

Business activity turnover details for Novartis India Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Novartis India Limited

Novartis India Limited is audited by B S R & Co. LLP for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
B S R & Co. LLP Locked Locked Locked
Premium access

Complete auditor history for Novartis India Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Novartis India Limited

Novartis India Limited is currently managed by 6 directors, with 21 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Sanker Parameswaran Director 22 Jun 2020 6 Years 0 Months Current
Shilpa Shashank Joshi Whole-Time Director 22 Nov 2022 3 Years 7 Months Current
Christopher David Snook Director 01 Aug 2008 17 Years 11 Months Current
Falin Ishwarlal Majmudar Whole-Time Director 28 Jun 2024 2 Years 0 Months Current
Gira Jagdeesh Sardesai Director 31 Mar 2024 2 Years 3 Months Current
Gowree Ashish Gokhale Director 01 Apr 2026 0 Years 3 Months Current

Financials of Novartis India Limited FY 2025 filings available

Novartis India Limited reported revenue of ₹398.23 Cr for FY 2025.

Revenue · FY 2025
₹398.23 Cr
Premium access

Ten-year financial statements for Novartis India Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Novartis India Limited

Premium access

Shareholding and ownership data for Novartis India Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Novartis India Limited

Open charges
₹0
Satisfied charges
₹257.48 Cr
Breakdown by lending institutions
Grindlays Bank₹111.60 Cr
Allahabad Bank₹45.00 Cr
Bnp Paribas₹33.00 Cr
Nationale De Paris French Bank Building₹32.50 Cr
The Industrial Credit and Investment Corpn. of India Ltd.₹20.00 Cr
Others₹15.38 Cr
Latest charge details
DateLenderAmountStatus
12 Apr 1999 Bnp Paribas ₹33 Cr Satisfied
02 May 1998 The Hongkong and Shanghai Banking Corporation Ltd. ₹5 Cr Satisfied
21 Jul 1993 Grindlays Bank ₹45 Cr Satisfied
21 Jul 1993 Allahabad Bank ₹45 Cr Satisfied
28 May 1992 Grindlays Bank ₹38 Cr Satisfied

Total charge records: 21 View all charges

Employees and EPFO Compliance at Novartis India Limited

Novartis India Limited has a workforce of 59 employees as of Apr 09, 2024.

Employee count
59
Active EPFO establishments
1
Employee growth
-16.9%
Premium access

Employee and EPFO history for Novartis India Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Novartis India Limited

Premium access

GST registrations and filing compliance for Novartis India Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Novartis India Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Novartis India Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Novartis India Limited

Premium access

MSME payment history for Novartis India Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Novartis India Limited

Premium access

Corporate group structure for Novartis India Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Novartis India Limited

Premium access

MCA filings and documents for Novartis India Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Novartis India Limited

Directors
01 Apr 2026
Gowree Ashish Gokhale was appointed as a Director on 01 Apr 2026 & has been associated with this company since 3 months 20 days.
Activity
31 Jul 2025
Novartis India Limited last Annual general meeting of members was held on 31 Jul 2025 as per latest MCA records.
Activity
31 Mar 2025
Novartis India Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Charges
20 Aug 2024
A charge registered on 06 Aug 1940 via Charge ID 90230132 with The National Bank Of India Ltd. was fully satisfied on 20 Aug 2024.
Charges
01 Jul 2024
A charge registered on 21 Jul 1993 via Charge ID 90228667 with Grindlays Bank was fully satisfied on 01 Jul 2024.
Charges
01 Jul 2024
A charge registered on 17 Aug 1982 via Charge ID 90227632 with Grindlays Bank was fully satisfied on 01 Jul 2024.

Frequently Asked Questions about Novartis India Limited

Novartis India Limited is an active public limited company in the pharma sector based in Bandra, Maharashtra, India. It was incorporated on 13 December 1947 (79+ years old) and is registered under CIN L24200MH1947PLC006104. Listed on BSE: 500672 and NSE: NOVARTIND. The company has 59 employees.

Novartis India Limited reported revenue of ₹398.23 Cr for FY 2025 (up 0.00% YoY).

The current directors of Novartis India Limited are:

The primary industry of Novartis India Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Yes. Novartis India Limited is listed on both BSE (code: 500672) and NSE (symbol: NOVARTIND).

Novartis India Limited can be reached at the registered office: Inspire Bkc 7Th Floor Bandra Kurla Complex, Bandra East, Maharashtra, India – 400051, or through the website novartis.in.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available